logo

For the Inventor, By the Inventor

Menlo Park, CA, United States of America

Cynthia W Tuthill

This inventor holds 8 USPTO granted patents and 17 published patent applications and 8 EPO patents. Top assignees: Sciclone Pharmaceuticals, Inc., Sciclone Pharmaceuticals International, Ltd., The University of Texas System. Active years: 2007-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cynthia W Tuthill. Retrieved from https://idiyas.com/inventor/cynthia-w-tuthill

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Menlo Park, CA (US) (2007 - 2014)
  • Hercules, CA (US) (2017 - 2023)

Company Filing History:

goldMedal7 out of 21 
 
Sciclone Pharmaceuticals, Inc.
 patents
silverMedal1 out of 4 
 
Sciclone Pharmaceuticals International, Ltd.
 patents
bronzeMedal1 out of 5,638 
 
The University of Texas System
 patents
where one patent can have more than one assignee

Years Active: 2007-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 11571465 - Treatment of cancer with alpha thymosin peptide and PD-1 inhibitors (2023-02-07),
2. 9724395 - Treatment of cancer with immune stimulators (2017-08-08),
3. 8716012 - Alpha thymosin peptides as vaccine enhancers (2014-05-06),
4. 8193152 - Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds (2012-06-05),
5. 8163702 - Treatment of melanoma (2012-04-24),
6. 7906486 - Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa (2011-03-15),
7. 7897567 - Methods of protecting against radiation damage using alpha thymosin (2011-03-01),
8. 7297676 - Thymosin alpha 1 peptide/polymer conjugates (2007-11-20),

Title: Innovations in Cancer Treatment by Cynthia W Tuthill

Introduction

Cynthia W Tuthill is a prominent inventor based in Menlo Park, California, known for her significant contributions to cancer treatment. With a total of eight patents to her name, she has focused her research on innovative methods to combat cancer through immune stimulation.

Latest Patents

Among her latest patents are groundbreaking inventions related to the treatment of cancer using alpha thymosin peptide and PD-1 inhibitors. These patents provide compositions and methods for treating cancer or its metastasis in a subject. The methods involve administering a composition that includes a therapeutically effective amount of at least one immune stimulator. In some cases, a combination of two immune stimulators is utilized, which may include an alpha thymosin peptide along with additional anti-cancer agents.

Career Highlights

Cynthia has worked with notable companies such as SciClone Pharmaceuticals, Inc. and SciClone Pharmaceuticals International, Ltd. Her work in these organizations has been instrumental in advancing cancer treatment methodologies.

Collaborations

Cynthia has collaborated with esteemed colleagues, including Alfred R Rudolph and Robert S King, contributing to the development of innovative cancer therapies.

Conclusion

Cynthia W Tuthill's work exemplifies the intersection of innovation and healthcare, particularly in the field of cancer treatment. Her patents and collaborations reflect her commitment to improving patient outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…